Private equity firms Blackstone Inc and Carlyle Group Inc are in talks about potentially teaming up on a bid for Swiss drugmaker Novartis’ generics unit, Bloomberg News reported on Tuesday, citing people with...
JBCPL to buy probiotic and reproductive brands from Sanzyme for Rs 628 crore
KKR-controlled drug maker JB Chemicals & Pharmaceuticals Limited (JBCPL), on Wednesday, announced that it will acquire probiotics and reproductive brands for the India market from Sanzyme Private Limited (Sanzyme)...
CCI approves GSK intra-group deal
Competition Commission of India (CCI) said on Monday it has cleared the acquisition of stake in GlaxoSmithKline Asia Pvt. Ltd. (GSKAPL ) by GlaxoSmithKline Consumer Healthcare Overseas Ltd. and GlaxoSmithKline Consumer...
Multiples Alternate buys into BDR Pharma, invests Rs 750 cr
Renuka Ramnath-led private equity (PE) fund Multiples Alternate Asset Management will invest around ₹750 crore to take an about 10% stake in Mumbai-based generic drugs manufacturer BDR Pharmaceuticals, multiple people...
Pharma firm La Renon acquires majority stake in Enaltec Labs
La Renon Healthcare, a pharmaceutical company backed by Sequoia Capital and A91 Partners, has acquired 51% stake in Enaltec Labs, a senior company official said. The deal values Enaltec at a post-money valuation of Rs...
CCI approves deal involving three GlaxoSmithKline group entities
Competition Commission of India (CCI) has cleared the proposed acquisition of consumer healthcare company GlaxoSmithKline Asia Pvt Ltd by two other GlaxoSmithKline group entities. GlaxoSmithKline Asia Pvt Ltd is into...
Polish drug maker Polpharma working on bid for Advent’s Zentiva – sources
Poland’s largest drug maker Polpharma is working on a possible $4 billion takeover of Czech rival Zentiva and is looking for investors to join its bid in return for a minority stake in the Advent International...
Fund Ardian buys Italy’s Biofarma, founding family keeps 30% stake
European private equity firm Ardian struck a deal to buy the majority of Italy’s Biofarma Group from White Bridge Investments in order to boost further the international growth of the drug company, a statement...
Aurobindo Pharma taps PEs for stake sale in injectable business
Aurobindo Pharma has initiated talks with private equity funds to sell a stake of around 30-35% in its injectable business for ₹4,500-5,250 crore ($600-700 million), as the Hyderabad-based drugmaker plans value...
Ajanta Pharma board approves up to Rs 286-crore share buyback plan
Drug firm Ajanta Pharma on Tuesday said its board has approved a share buyback plan of up to Rs 286-crore, wherein the drug maker will buy back shares at a maximum price of Rs 2,550 apiece. The company’s board has...
Australia’s Wesfarmers won’t back Woolworths’ $613 mln bid for API
Wesfarmers said on Wednesday it would not back a bid by Woolworths to buy Australian Pharmaceutical Industries, and has taken steps to settle concerns raised by some stakeholders of the country’s top drugstore...
Natco board approves proposal to acquire US-based pharma company
Natco Pharma on Tuesday said its board has approved a proposal to acquire US-based Dash Pharmaceuticals LLC for a cash consideration of USD 18 million. The company’s board has approved to acquire Dash...
